Skip To Main Content
Gerry Smith on Muck Rack

Gerry Smith

Verified
New York
As seen in: UOL Economia, CNN, Medium, MSN, MSN Philippines, MSN Singapore, The New York Times, UOL, Bloomberg Businessweek, Bloomberg Green Daily and
Covers:  hackers, telecom, cybersecurity
Freelance reporter for The New York Times, CNBC and others. Email: gerryfsmith@gmail.com

Get in touch with Gerry

Contact Gerry, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Gerry Smith’s Biography

Read Full Bio →

Technology Reporter, The Huffington Post

Gerry Smith’s Journalist Portfolio

How The iPhone Became An Object Worth Killing For

How The iPhone Became An Object Worth Killing For

When Sunah Yang bought an iPhone for her brother two years ago, she warned him about the white earbuds. Never…

View article →

Articles

The Last High School Football Team in Town

|
By Gerry Smith Verified, Jose Alvarado Jr.
| The New York Times Verified
The Last High School Football Team in Town - The New York Times
Open in Who Shared Issue with article?

When the Family Beach House Becomes a Point of Tension

|
By Gerry Smith Verified
| The New York Times Verified
You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load. When the Family Beach House Becomes a Point of Tension A record percentage of U.S. property transfers last year were through inheritance, but taking over a home with sentimental value can be fraught.
Open in Who Shared Issue with article?

New bipartisan bill aims to speed up clinical trials for rare disease treatments

|
By Gerry Smith Verified
| MSN Verified
A new bipartisan bill aims to accelerate the development of rare disease treatments by making clinical trials faster, cheaper and more accessible to patients. The legislation would create networks of reusable clinical trial sites and allow more patients to participate in studies from their homes or doctors' offices. The bill calls for up to $295 million in FDA funding over five years, with a goal of reducing the cost and time needed to enroll clinical trial participants by at least 30%.
Open in Who Shared Issue with article?
See all 5,733 licensed articles (6,287 Total)